Loading...
The AUA and SUO have issued a new two-part guideline on detecting prostate cancer: Part 1 addresses screening, and part 2 addresses considerations related to biopsy. Many of the 35 recommendations are relevant mainly to urologists; here, we highlight recommendations of interest to primary care clinicians.
The authors begin by stating that “prostate cancer screening is a preference-sensitive decision,” and, throughout the document, they strongly emphasize shared decision making.
For average-risk patients who choose to be screened, prostate-specific antigen (PSA) testing should be offered every 2 to 4 years for middle-aged …
